ABSTRACT Aims/Introduction: Overproduction of reactive oxygen species (ROS) in endothelial cells (ECs) plays a pivotal role in endothelial dysfunction. Mitochondrial ROS (mtROS) is one of the key players in the pathogenesis of diabetic vascular complications. Hypoglycemia is linked to increased ROS production and vascular events; however, the underlying mechanisms remain unclear. In the present study, we aimed to determine whether and how low glucose (LG) mediates mtROS generation in ECs, and to examine the impact of LG-induced mtROS on endothelial dysfunction. Materials and Methods: Metabolomic profiling, cellular oxygen consumption rate, mtROS, endothelial nitric oxide synthase phosphorylation, and the expression of vascular cell adhesion molecule-1 or intercellular adhesion molecule-1 were evaluated in bovine aortic ECs. Results: We found that LG increased mtROS generation in ECs; which was suppressed by overexpression of manganese superoxide dismutase. Comprehensive metabolic analysis using capillary electrophoresis-mass spectrometry and oxygen consumption rate assessment showed that the pathway from fatty acid to acetyl-CoA through fatty acid oxidation was upregulated in ECs under LG conditions. In addition, etomoxir, a specific inhibitor of the free fatty acid transporter, decreased LG-induced mtROS production. These results suggested that LG increased mtROS generation through activation of fatty acid oxidation. We further revealed that LG inhibited endothelial nitric oxide synthase phosphorylation, and increased the expression of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1. These effects were suppressed either by overexpression of manganese superoxide dismutase or by treatment with etomoxir. Conclusions: The activation of fatty acid oxidation followed by mtROS production could be one of the causes for endothelial dysfunction during hypoglycemia.
INTRODUCTION
Overproduction of reactive oxygen species (ROS) caused by several factors, such as diabetes, obesity, hypertension, hyperlipidemia and smoking, plays a pivotal role in the pathogenesis of cardiovascular diseases. Excess production of ROS can promote endothelial dysfunction, which is thought to play an important role not only in the initiation of atherosclerosis, but also in the etiology of diabetic vascular complications [1] [2] [3] [4] . Therefore, to prevent diabetic vascular complications, it is essential to elucidate the mechanisms of ROS generation in the context of diabetes.
The Diabetes Control and Complications Trial 5 , the United Kingdom Prospective Diabetes Study 6 , and our Kumamoto Study 7 provide strong evidence that hyperglycemia plays an important role in the pathogenesis of microvascular complications in both type 1 and type 2 diabetes. In addition, hyperglycemia-induced ROS generation has been reported to be involved in vascular endothelial dysfunction in patients with diabetes 4 . Consistent with these reports, Nishikawa et al. proposed that mitochondrial ROS (mtROS) is the major cause of diabetes-induced oxidative stress in endothelial cells (ECs) 8 . Recent large randomized clinical trials have shown that intensive glycemic control might fail to reduce macrovascular events 9 . Along with improvements in diabetes management with insulin or insulin secretagogues, there has been an increase in the prevalence of hypoglycemia with efforts to achieve better glycemic control. Severe hypoglycemia is strongly associated with an increased risk for vascular events and death. However, it is not clear whether there is a causal relationship between hypoglycemia and these outcomes 10 . Hypoglycemic events can trigger inflammation, blood coagulation abnormalities, the sympathoadrenal response and endothelial dysfunction, and these responses are interdependent. As a result, endothelial dysfunction mediated by hypoglycemic abnormalities could contribute to cardiovascular risk 11 . Previous studies have reported that hypoglycemia induces oxidative stress in type 1 diabetes 12 , and that recurrent hypoglycemia potentiates longterm hyperglycemia-mediated impairment of hippocampal mitochondria and increases the oxidative stress 13 . Therefore, oxidative stress in ECs might be a common factor linking hyperglycemia, hypoglycemia and the vascular complications of diabetes.
Therefore, the aims of the present study were to evaluate whether low glucose (LG) conditions exacerbated mtROS in ECs, similarly to high glucose conditions, and to evaluate whether the suppression of LG-induced mtROS could ameliorate endothelial dysfunction. Elucidation of the mechanisms by which hypoglycemia promotes endothelial dysfunction might help to prevent diabetic complications.
METHODS

Cell culture conditions and materials
Bovine aortic endothelial cells were purchased from TOYOBO (Osaka, Japan). Cells were cultured in Dulbecco's modified Eagle's medium (Wako, Osaka, Japan) with 10% fetal bovine serum and 1.0, 2.5, 4.0, 5.5 or 25 mmol/L glucose in an atmosphere containing 5% CO 2 and 95% air at 37°C. Etomoxir, 1-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride (trimetazidine), bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl) ethyl sulfide and carbonyl cyanide 3-chlorophenylhydrazone were from Sigma-Aldrich (St. Louis, Missouri, USA).
Adenoviral vectors
Human manganese superoxide dismutase (MnSOD) adenoviral vectors were provided by Dr M Brownlee (Albert Einstein College of Medicine, Bronx, New York, USA) 8 . Cells were infected with MnSOD adenovirus or lacZ control adenovirus 48 h before experiments. MnSOD overexpression was confirmed using western blot analysis, as previously described 14 .
Measurement of mtROS generation
To evaluate the direct generation of mtROS, we used the reduced MitoTracker Red CM-H2XRos probe (ThermoFisher Scientific, Waltham, Massachusetts, USA), which specifically detects the ROS generation in mitochondria 15 . Cells were incubated with 300 nmol/L MitoTracker Red CM-H2XRos at 37°C for 30 min before the end of the experiment.
Measurement of MnSOD activity
MnSOD activity was measured using a SOD assay kit-WST (Dojindo, Kumamoto, Japan), according to the manufacturer's instructions.
Measurement of metabolites
Measurement of metabolites was carried out according to the manufacturer's instructions (Human Metabolome Technologies, Inc., Tsuruoka, Japan) as follows. Culture cells (8 9 10 6 cells/ sample) were used for the extraction of intracellular metabolites. Culture medium was aspirated from the dish, and cells were washed twice with 5% mannitol solution (10 mL first and then 2 mL). Cells were then treated with 800 lL methanol, and left to rest for 30 s to inactivate enzymes. Next, the cell extract was treated with 550 lL Milli-Q water containing internal standards (H3304-1002; Human Metabolome Technologies, Inc.), and left to rest for another 30 s. The extract was obtained and centrifuged at 2,300 g and 4°C for 5 min, and 700 lL of the upper aqueous layer was then filtered by centrifugation through a Millipore 5-kDa cut-off filter at 9,100 g and 4°C for 120 min to remove proteins. The filtrate was concentrated by centrifugation and resuspended in 50 lL Milli-Q water for capillary electrophoresis-mass spectrometry.
Respirometry (Extracellular Flux Analysis)
The oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) were measured using an intact cell respirometer designed for adherent cells (XF-24 Extracellular Flux Analyzer; Seahorse Bioscience, North Billerica, Massachusetts, USA). Bovine aortic endothelial cells were seeded at a density of 10,000 cells/well in 24-well plates designed for respirometer analysis. Cells reached confluency and were subjected to respirometry at 2 days after seeding.
Mitophagy detection
Mitophagy was evaluated using a Mitophagy Detection Kit (Dojindo), according to the manufacturer's instructions.
Western blot analysis
Western blot analysis was carried out as previously described 14 . 
Statistical analysis
Data are presented as mean -SD. Statistical analysis was carried out using unpaired Student's t-tests for two-group comparisons and one-way analysis of variance (ANOVA) followed by Tukey's multiple comparison tests or Games-Howell multiple comparison tests for more than two groups using SPSS software (ver. 21; IBM, Armonk, New York, USA). A P-value of <0.05 was considered statistically significant.
RESULTS
LG induced mtROS production in ECs To determine whether LG could induce mtROS production, we used the reduced MitoTracker Red CM-H2XRos probe in ECs. The fluorescence intensity of the MitoTracker Red CMH2XRos probe was significantly increased in ECs cultured with 2.5 mmol/L glucose (149.4 -11.5% that of 5.5 mmol/L glucose) compared with that of 5.5 mmol/L glucose. MitoTracker Red CM-H2XRos fluorescence was suppressed with overexpression of MnSOD, a specific SOD targeting mtROS (Figure 1a,b) . Additional experiments confirmed that lower glucose levels induced greater MitoTracker Red CM-H2XRos fluorescence in ECs independent of osmotic pressure (Figure 1c,d) . In contrast, MnSOD activity and the glutathione-to-glutathione disulfide ratio in ECs did not change under LG conditions (Figure 1e ; Table 1 ). We also investigated the dose-dependent effects of glucose on mtROS generation. The fluorescence intensity of the MitoTracker Red CM-H2XRos probe was significantly increased in ECs cultured with 2.5 mmol/L glucose compared with that of 4.0 mmol/L glucose, and was comparable with that of 1.0 mmol/L glucose. In contrast, the MitoTracker Red CMH2XRos fluorescence of 25 mmol/L glucose was significantly higher than that of 2.5 mmol/L glucose (Figure 1f,g ). In addition, we investigated whether fluctuations in glucose levels influenced mtROS generation. The fluorescence intensity of the MitoTracker Red CM-H2XRos probe was significantly increased in ECs cultured with 25 mmol/L glucose for 1 h and 2.5 mmol/L glucose for 1 h compared with that in ECs cultured with 5.5 mmol/L glucose for 1 h and 2.5 mmol/L glucose for 1 h (Figure 1h ,i).
LG stimulation increased fatty acid oxidation in ECs To investigate the mechanism through which LG induces mtROS, metabolomic profiling was carried out using capillary electrophoresis-time-of-flight mass spectrometry in ECs treated with either 2.5 or 5.5 mmol/L glucose (Figure 2a ). Metabolome analysis showed that levels of intermediate metabolites in glycolysis, such as fructose 1,6-diphosphate, 3-phosphoglyceric acid, 2-phosphoglyceric acid, phosphoenolpyruvic acid, pyruvic acid and lactic acid, decreased with 2.5 mmol/L glucose treatment for 1 h compared with that of normal glucose treatment (Table 1) . However, treatment of ECs with 2.5 mmol/L glucose did not alter the levels of adenosine triphosphate, guanosine 5 0 -triphosphate or tricarboxylic acid cycle metabolites, such as citric acid, isocitric acid and succinic acid. Interestingly, acetylCoA levels were not altered with LG stimulation. Acetyl-CoA can be synthesized through fatty acid oxidation (FAO), as well as glycolysis (Figure 2a ; Table 1 ). The levels of metabolic intermediates of glutamine did not change in ECs under LG conditions (Table 1) . These results show that the pathway from fatty acid to acetyl-CoA through FAO was upregulated in ECs during LG stimulation.
To characterize FAO-associated metabolic changes, an extracellular flux analyzer was used to assess the OCR, which mainly reflects mitochondrial oxidative phosphorylation activity. Without palmitic acid, there was no significant difference between the basal OCR under normal glucose conditions and that under LG conditions. In contrast, compared with that in ECs under normal glucose conditions, treatment with 100 lmol/L palmitic acid increased the basal OCR in ECs under LG conditions (189.8 -10.4 vs 225.9 -9.2 pmol/min, respectively; P < 0.01), suggesting a high rate of FAO under LG conditions (Figure 2b) .
CPT1 is the rate-limiting enzyme that transfers long-chain fatty acyl-CoA to the mitochondria for beta-oxidation, and is inhibited by unphosphorylated ACC 16 . When treated with etomoxir, a CPT1 inhibitor, enhancement of the basal OCR in ECs under LG conditions with palmitic acid treatment was reduced to the level observed with normal glucose conditions (213.5 -6.1 vs 168.6 -11.0 pmol/min, respectively; P < 0.01; Figure 2c ).
Furthermore, we evaluated the ECAR, which is used as a measure of anaerobic glycolysis, as it mainly reflects the production of lactate, under LG conditions. Without palmitic acid, the basal ECAR in ECs under LG conditions decreased compared with that in ECs under normal glucose conditions (8.0 -0.9 vs 9.0 -1.0 mpH/min, respectively; P < 0.01), suggesting a decrease in glycolytic metabolism to lactate 
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( Figure 2d ). In contrast, with palmitic acid, there was no significant difference between the basal ECAR under normal glucose conditions and that under LG conditions. When treated with etomoxir, ECARs in ECs under normal glucose and LG conditions decreased compared with those in ECs that were not treated with etomoxir. However, when treated with palmitic acid and etomoxir, there was no significant difference between the basal ECAR under normal glucose conditions and that under LG conditions (Figure 2e ).
We next examined the effects of LG conditions on ACC activity. Treatment with LG increased the phosphorylation of ACC at Ser 79 after 30 and 60 min of incubation, which indicated the inactivation of ACC (Figure 2e) . Therefore, LG stimulation increased the rate of mitochondrial beta-oxidation through inhibition of ACC and activation of CPT1 in ECs. Furthermore, we investigated CPT1 expression by western blot analysis and quantitative reverse transcription PCR, and evaluated the mitophagy status of bovine aortic endothelial cells. LG Data are mean -standard deviation (n = 3/group). ATP, adenosine triphosphate; GSH, glutathione; GSSG, glutathione-SS-glutathione; GTP, guanosine 5´-triphosphate. conditions had no significant effect on CPT1 expression or mitophagy status compared with normal glucose conditions ( Figure S1 ).
LG increased mtROS generation through activation of FAO To confirm the source of mtROS production during LG stimulation, ECs under LG conditions were supplemented with etomoxir or trimetazidine. When ECs were cultured under normal or high glucose conditions, there were no significant differences in the reduced MitoTracker Red CM-H2XRos fluorescence intensities of cells treated with vehicle or etomoxir (Figure 3a ,c, d,f,g). In contrast, treatment of cells with LG conditions increased the fluorescence of MitoTracker Red CM-H2XRos, which was completely suppressed by etomoxir (Figure 3b,e,g ). In addition, we evaluated the effects of trimetazidine, another pharmacological FAO inhibitor, on LG-induced mtROS generation. Trimetazidine is a competitive inhibitor of 3-ketoacyl CoA thiolase, a key enzyme in beta-oxidation. Trimetazidine suppressed LG-induced mtROS generation as with etomoxir (Figure 3h-n) . We also evaluated the effects of bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl) ethyl sulfide, a selective inhibitor of glutaminase. Glutaminase converts glutamine to glutamate, and can be further oxidized to a-ketoglutarate to feed the tricarboxylic acid cycle. Bis-2-(5-phenylacetamido-1,3,4-thiadiazol-2-yl) ethyl sulfide had no effect on mtROS production under LG conditions (Figure 3o-s) .
LG inhibited eNOS activation and increased the expression of vascular adhesion molecules To determine whether LG stimulation affected endothelial function, we examined eNOS activation by measuring its phosphorylation at Ser 1177 . As shown in Figure 4a, LG stimulation inhibited the phosphorylation of eNOS, and this effect was suppressed by MnSOD overexpression or etomoxir treatment. We next examined the expression of the vascular adhesion molecules, VCAM-1 and ICAM-1, in ECs. VCAM-1 and ICAM-1 messenger RNA expression levels were significantly increased by incubation with LG compared with those in cells cultured under normal glucose conditions. In addition, LG-induced messenger RNA induction was suppressed by MnSOD overexpression or incubation with etomoxir (Figure 4b,c) . These results suggested that activated FAO induced by LG stimulation caused endothelial dysfunction.
DISCUSSION
In the present study, we found that LG conditions increased the production of mtROS in ECs. Although downregulation of intermediate metabolites in glycolysis was observed in ECs under LG conditions by metabolome analysis, there were no changes on intracellular acetyl-CoA, adenosine triphosphate or tricarboxylic acid cycle metabolites, suggesting that other pathways without glycolysis were involved in maintaining the tricarboxylic acid cycle. Additionally, we found that blockade of FAO prevented the increased oxygen consumption rate with palmitic acid stimulation and decreased LG-mediated mtROS production. In general, FAO generates just 5% of the total amount of adenosine triphosphate of ECs under normal glucose conditions 17 , and many cancer cells increase glucose and glutamine uptake to fuel the tricarboxylic acid cycle 18, 19 . However, our novel findings suggested that the tricarboxylic acid cycle was maintained by increasing FAO, thereby increasing mtROS production in ECs under LG conditions. Accelerated beta-oxidation of palmitate caused excess electron flux in the mitochondrial respiratory chain, resulting in increased ROS generation in H4IIEC3 hepatocytes 20 . Taken together, these findings suggested that excess fatty acid oxidation could, at least in part, induce ROS generation in ECs. In contrast, Nakamura et al. 20 reported that palmitate might induce the CPT1 gene expression, and LG conditions had no significant effect on CPT1 expression in the present study. Therefore, the mechanism for increasing FAO under LG conditions remains unclear, and further studies are necessary to determine this mechanism.
Acute infusion of free fatty acids (FFAs) induces oxidative stress and reduces endothelium-dependent vasodilation in humans in vivo 21 . Furthermore, treatment with FFAs impairs endothelial function by several mechanisms, including increased production of ROS, stimulation of pro-inflammatory signaling, and reduction of eNOS activity and nitric oxide (NO) production [22] [23] [24] . Furthermore, overexpression of uncoupling protein-2, an important regulator of intracellular ROS production, . Therefore, accumulation of FFAs might mediate endothelial dysfunction under hypoglycemic condition.
Hypoglycemia, mediated by intensive glucose-lowering interventions, is a common side-effect in patients with diabetes, and might increase the risk of poor outcomes 26, 27 . Additionally, ECs play important roles not only as vessel barriers, but also in the regulation of vascular tone, coagulation, leukocyte adhesion and vascular permeability. Vascular tone is modulated by various factors, such as NO. The earliest and most important factor mediating endothelial dysfunction is a reduction in NO bioactivity, which is mediated by ROS. Therefore, ROS generation in vascular cells plays a key role in endothelial dysfunction and subsequent atherosclerotic lesion formation 23 . Furthermore, hypoglycemia induces endothelial dysfunction through the production of several inflammatory factors, including VCAM-1, ICAM-1, vascular endothelial growth factor, interleukin-8, interleukin-6, endothelin-1 and tumor necrosis factor-alpha, resulting in increased risk of diabetic macro-angiopathy 11, [28] [29] [30] . In particular, Jin et al. 31 reported that hypoglycemia increases serum adrenaline and levels of adhesion molecules, such as VCAM-1 and ICAM-1, in the endothelium of the rat aorta. In addition, increased ROS also activates nuclear factor-jB, which mediates the overexpression of adhesion molecules, such as VCAM-1, ICAM-1 and E-selectin 32 . In the present study, we observed that LG stimulation decreased the bioavailability of NO, and increased the expression of VCAM-1 and ICAM-1 in ECs. Furthermore, blockade of FAO or suppression of mtROS ameliorated the LG-induced bioavailability of NO, and expression of VCAM-1 and ICAM-1. These results suggested that hypoglycemia-induced reduction of NO bioactivity, and overproduction of VCAM-1 and ICAM-1 messenger RNA were mediated by the overproduction of mtROS and activation of FAO in ECs.
The present findings might have implications in both diabetic macro-angiopathy and diabetic micro-angiopathy. In fact, our preliminary data showed that etomoxir decreased ROS generation and prevented vascular permeability caused by recurrent hypoglycemia in the retinas of diabetic mice (unpubl. data). Interestingly, Schoors et al. 33 reported that etomoxir also reduces pathological angiogenesis in a model of oxygen-induced retinopathy. We therefore speculate that mtROS and FAO might be involved in the progression of microvascular complications caused by recurrent hypoglycemia.
The present analysis was limited by the fact that we did not examine whether LG induced ROS generation, and whether ROS-mediated endothelial dysfunction was inhibited by blockade of FAO in animal models. Therefore, further studies are required to evaluate the association of hypoglycemia and diabetic complications in vivo. Furthermore, ketone bodies play an important role as alternative energy sources to neurons during hypoglycemia 34 . Rains et al. 35 reported that hyperketonemia increases monocyte adhesion to ECs. Based on these previous reports, additional studies are also required to investigate the effects of ketone bodies on ECs during hypoglycemia in vivo. Such studies are necessary to determine whether arteriosclerosis progression as a result of monocyte adhesion or macrophage infiltration is mediated by enhancement of fatty acid metabolism in the context of recurrent hypoglycemia in diabetic mice in vivo.
In conclusion, we showed that LG conditions exacerbated mtROS production through activation of FAO in ECs (Figure 5 ). In addition, we revealed that blockade of FAO suppressed LG-mediated mtROS production and ameliorated LG-induced endothelial dysfunction. Collectively, the present findings suggested that inhibition of FAO and subsequent suppression of mtROS generation could be novel therapeutic approaches for the prevention of endothelial dysfunction and diabetic macrovascular complications under hypoglycemic conditions.
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